Audubon Manning Veterinary Clinic (AMVC)

Global CBD Pet Market Report (2022 to 2027) - Featuring Green Mountain Animal, Green Roads and Honest Paws Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022

Market dynamics are forces that impact the prices and behaviors of the Global CBD Pet Market stakeholders.

Key Points: 
  • Market dynamics are forces that impact the prices and behaviors of the Global CBD Pet Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global CBD Pet Market.
  • The Global CBD Pet Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global CBD Pet Market.

Insights on the Companion Animal Health Global Market to 2027 - Growing Prevalence of Animal Diseases Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 31, 2022

The Global Companion Animal Health Market is estimated to be USD 28.69 Bn in 2022 and is expected to reach USD 47.46 Bn by 2027, growing at a CAGR of 10.59%.

Key Points: 
  • The Global Companion Animal Health Market is estimated to be USD 28.69 Bn in 2022 and is expected to reach USD 47.46 Bn by 2027, growing at a CAGR of 10.59%.
  • Market dynamics are forces that impact the prices and behaviors of the Global Companion Animal Health Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global Companion Animal Health Market.
  • The Global Companion Animal Health Market is segmented based on Indication, Animal, Distribution Channel, and Geography.

Global DNA Vaccines Market Report 2022-2027: Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals Driving Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 31, 2022

The Global DNA Vaccines Market is segmented based on Product Type, Type, End Userand Geography.

Key Points: 
  • The Global DNA Vaccines Market is segmented based on Product Type, Type, End Userand Geography.
  • By Type, the market is classified into Therapeutic Vaccines and Prophylactic Vaccines.
  • The report presents a detailed Ansoff matrix analysis for the Global DNA Vaccines Market.
  • The report analyses the Global DNA Vaccines Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Europe Dog Dewormers Market Report 2022: Featuring Key Players Merck & Co, Boehringer Ingelheim, Virbac, Elanco, Ceva, Zoetis, PetIQ & Sava Healthcare - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 20, 2022

Europe's dog dewormers market size is expected to reach USD 793.2 million by 2030.

Key Points: 
  • Europe's dog dewormers market size is expected to reach USD 793.2 million by 2030.
  • The rising canine population along with their ownership and growing expenditure on dogs are major factors propelling the market growth.
  • The European market for dog dewormers is expected to grow notably in the coming years.
  • Chapter 3 Europe Dog Dewormers Market Variables, Trends & Scope
    Chapter 4 Europe Dog Dewormers Market: Segment Analysis, By Distribution Channel, 2017-2030 (USD Million)
    Chapter 5 Europe Dog Dewormers Market: Country Market Analysis 2017-2030 (USD Million)

Sheridan Capital Partners Invests in RS&A

Retrieved on: 
Wednesday, June 22, 2022

Sheridan Capital Partners (Sheridan) announced today its investment in RS&A, LLC (RSA), an established medical device independent service provider (ISP) based out of Rural Hall, NC.

Key Points: 
  • Sheridan Capital Partners (Sheridan) announced today its investment in RS&A, LLC (RSA), an established medical device independent service provider (ISP) based out of Rural Hall, NC.
  • The transaction was led by Sean Dempsey, Nicholas Rowland, Matt Collins, and Liam McDonald at Sheridan Capital Partners.
  • McGuire Woods LLP served as legal counsel to Sheridan Capital Partners.
  • Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada.